Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Transitional Cell

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

430 public trials 126 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Not yet recruiting

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

NCT07189793

Conditions: Carcinoma, Carcinoma in Situ, Carcinoma in Situ of Bladder, +16 more
Locations: The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

NCT07807345

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +49 more
Locations: UCSD Moores Cancer Center La Jolla, California, United States

SCRI at Florida Cancer Specialists Orlando, Florida, United States

Massachusetts General Brigham Boston, Massachusetts, United States

OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States

View Trial Details

Not yet recruiting

Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

NCT07789119

Conditions: Biospecimens, Carcinoma, Carcinoma, Transitional Cell, +7 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)

NCT07744958

Conditions: Carcinoma, Carcinoma, Transitional Cell, Muscle Invasive Bladder Cancer (MIBC), +3 more
Locations: Not specified

View Trial Details

Not yet recruiting

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

NCT07671092

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations: Research Facility Christchurch, New Zealand

View Trial Details

Not yet recruiting

FAPI PET Imaging - An Exploratory Study

NCT07705074

Conditions: Adenocarcinoma, Adenoma, Blood Protein Disorders, +80 more
Locations: Kantonsspital Baden Baden, Canton of Aargau, Switzerland

Hôpitaux Universitaires de Genève (HUG) Geneva, Canton of Geneva, Switzerland

Luzerner Kantonsspital Lucerne, Canton of Lucerne, Switzerland

Clinique de Genolier Genolier, Canton of Vaud, Switzerland

View Trial Details

Not yet recruiting

Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)

NCT07662863

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma

NCT07636772

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Not yet recruiting

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

NCT07631884

Conditions: Advanced Malignant Solid Neoplasm, Biliary Tract Diseases, Biliary Tract Neoplasms, +56 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of Peripheral Neuropathy in Patients With Advanced Urothelial Cancer Treated With Enfortumab Vedotin and Pembrolizumab With Supportive Neuridase (ENDEAVOR)

NCT07629700

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +7 more
Locations: Not specified

View Trial Details